Shenzhen-based Mindray Medical International, one of China’s leading medical-device makers, will acquire the patient-monitoring business line of US firm Datascope for US$202 million, the Wall Street Journal reported. The purchase of the New Jersey firm’s business, which had revenues of US$161.3 million in 2007, will give Mindray access to Datascope’s force of around 90 sales and service representatives. Mindray was founded in 1991 and manufacturers patient monitors, blood analyzers, ultrasound equipment and other products. Datascope reported revenues of US$378.8 million for its last full fiscal year. UBS AG advised Mindray on the deal. Lehman Brothers advised Datascope.